Select for export Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s2215-0366(15)00576-3 PubMed 27067625 Copy citation Copy BibTeX Unknown journal 2016-04-04 Mithoefer MC, Grob CS, Brewerton TD. Europe PMC Published psilocybin AnxietyPTSDAddiction Randomized Controlled Trial More
Select for export Exploring Hallucinogen Pharmacology and Psychedelic Medicine with Zebrafish Models. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/zeb.2016.1251 PubMed 27002655 Copy citation Copy BibTeX Unknown journal 2016-03-21 Kyzar EJ, Kalueff AV. Europe PMC Published psilocybin DepressionAnxietyPTSD Animal Study More
Select for export The Effect of 5-HT2A/1a Agonist Treatment On Social Cognition, Empathy, and Social Decision-making Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s0924-9338(15)30017-1 Copy citation Copy BibTeX European Psychiatry 2015-02-28 Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, I. Dziobek, Philipp Stämpfli, F.X. Vollenweider OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881114568040 PubMed 25670401 Copy citation Copy BibTeX Journal of psychopharmacology (Oxford, England) 2015-02-28 Majić T, Schmidt TT, Gallinat J PubMed Published psilocybin AnxietyAddictionOCD Clinical Trial More
Select for export Psilocybin and Obsessive Compulsive Disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2014.963754 PubMed 25364991 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2014-10-31 Wilcox JA. Europe PMC Published psilocybin AnxietyOCDReceptor Pharmacology Other More
Select for export Stanislav Grof's Contributions to FDA Drug Development Research with Psychedelics Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX CIIS Digital Commons (California Institute of Integral Studies) 2013-12-31 Rick Doblin OpenAlex Published psilocybin AnxietyPTSDAddiction Clinical Trial More
Select for export The Heffter Research Institute: past and hopeful future. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2014.873688 PubMed 24830182 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2013-12-31 Nichols DE. Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export Psychedelics and mental health: a population study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0063972 PubMed 23976938 Copy citation Copy BibTeX PLoS ONE 2013-08-18 Krebs TS, Johansen PØ. Europe PMC Published psilocybin DepressionAnxietyPTSD Observational Study More
Select for export Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1503/jpn.120128 Copy citation Copy BibTeX Фундаментальные исследования (Fundamental Research) 2013-02-28 Young SN. Europe PMC Published psilocybin DepressionAnxietyMechanism of Action Clinical Trial More
Select for export Other Times I Can Barely See: The Effects of Hallucinogens on Vision and Attention Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX eScholarship (California Digital Library) 2009-12-31 Matthew J. Baggott OpenAlex Published psilocybin AnxietyMechanism of ActionReceptor Pharmacology Other More
Select for export Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.4088/jcp.v67n1110 PubMed 17196053 Copy citation Copy BibTeX The Journal of Clinical Psychiatry 2006-10-31 Moreno FA, Wiegand CB, Taitano EK, Delgado PL. Europe PMC Published psilocybin AnxietyOCDChronic Pain Other More
Select for export Hallucinogens Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1542/pir.27.8.314 Copy citation Copy BibTeX Pediatrics in Review 2006-07-31 David L. Eldridge, Karin Hillenbrand OpenAlex Published psilocybin AnxietyAddictionEnd-of-Life Distress Case Report More
Select for export Hallucinogen persisting perception disorder after psilocybin consumption: a case study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.eurpsy.2005.04.008 PubMed 15963699 Copy citation Copy BibTeX European Psychiatry 2005-07-31 Espiard ML, Lecardeur L, Abadie P, Halbecq I, Dollfus S. Europe PMC Published psilocybin DepressionAnxietyAddiction Other More
Select for export Serotonin, psilocybin, and body dysmorphic disorder: a case report. No abstract availability was recorded for this entry. Details DOI 10.1097/00004714-199604000-00011 PubMed 8690834 Copy citation Copy BibTeX Unknown journal 1996-03-31 Hanes KR. Europe PMC Published psilocybin AnxietyReceptor PharmacologyCase Report Case Report More
